文献速递头颈部肿瘤放疗中枢神经肿瘤放疗乳腺癌放疗

再程放疗的历史传承:历史文献叙述性综述

Preserving the legacy of reirradiation: A narrative review of historical publications.
PubMed 文献 · Adv Radiat Oncol · 2017-02-28

本叙述性综述梳理20世纪(尤其1920至1960年间)再程放疗的历史发展脉络,涵盖血液系统恶性肿瘤与实体瘤的再次放疗实践。文献以回顾性单中心分析为主,涉及外照射、近距离治疗及其联合应用,并常报告毒性与生存数据;先驱者已关注晚期组织变化、个体化治疗及患者选择等至今仍被讨论的挑战。

要点

  • 再程放疗历史适应证包括局部复发、区域淋巴结复发及既往照射区内第二原发肿瘤。
  • 历史文献多为回顾性单中心分析,治疗方式含外照射、近距离治疗或两者联合。
  • 先驱者已提出晚期组织变化、个体化方案及再程放疗患者选择等核心问题。

核心结论

  • 再程放疗在20世纪数十年间已用于血液系统恶性肿瘤和实体瘤,先驱者已认识到今日仍在讨论的晚期组织变化、个体化治疗与患者选择等挑战。

研究设计与样本

  • 采用叙述性综述形式,因历史文章异质性大,许多情况下无法系统提取基线数据、治疗细节或随访信息。

主要发现

  • 再程放疗适应证包括局部复发、区域淋巴结复发及既往治疗区域内发生的第二原发肿瘤。
  • 文献为回顾性单中心分析,描述的治疗方式包括外照射放疗、近距离放疗或两者联合。
  • 所纳入文献常提供毒性反应和生存数据。
  • 综述涵盖乳腺癌及妇科、头颈、脑和皮肤肿瘤等病种。

关键数值与推荐

  • 综述覆盖时间为20世纪数十年,尤其聚焦1920年至1960年间。

临床怎么用

  • 历史经验提示再程放疗需关注晚期组织变化,并重视个体化治疗与获益患者的选择。

局限性

  • 因历史文章异质性大,许多病例无法系统提取基线数据、治疗细节或随访信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study is to illustrate the historical development of reirradiation during several decades of the 20th century, in particular between 1920 and 1960. METHODS AND MATERIALS: We chose the format of a narrative review because the historical articles are heterogeneous. No systematic extraction of baseline data, treatment details, or follow-up care was possible in many cases. RESULTS: Both hematological malignancies and solid tumors were treated with a second course of radiation therapy, and indications included local relapse, regional nodal recurrence, and second primary tumors developing in a previously treated region. The literature consists of retrospective single-institution analyses describing treatment approaches that included external beam radiation therapy, brachytherapy, or combinations thereof. Data on toxicities and survival were often provided. Breast cancer and gynecological, head and neck, brain, and skin tumors are among the entities included in this review. CONCLUSIONS: The leading pioneers in the field are fully aware of many of the challenges we continue to debate today. These include the process of late tissue changes and development of personalized treatment approaches and better ways to select patients who are likely to benefit from a second course of radiation therapy.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Nieder C, Langendijk JA, Guckenberger M, et al. Preserving the legacy of reirradiation: A narrative review of historical publications. Adv Radiat Oncol. 2017. PMID: 28740929. doi:10.1016/j.adro.2017.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。